SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Operating income 2021–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) annual operating income history from SEC filings — each fiscal year as reported.
-$7.5MFY2025 · since FY2021: -$10.9M → -$7.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.5M | +12.7% |
| FY2024 | -$8.6M | +11.0% |
| FY2023 | -$9.7M | +12.3% |
| FY2022 | -$11.1M | -1.8% |
| FY2021 | -$10.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SCNI financial trends
SCNI RevenueSCNI Net incomeSCNI Net marginSCNI Gross profitSCNI Gross marginSCNI Operating marginSCNI Operating cash flowSCNI Free cash flowSCNI Capital expendituresSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →